日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development

蛋白酶抑制剂对 SARS-CoV-2 和人鼻病毒的双重抑制正在临床开发中

Cheng Liu, Sandro Boland, Michael D Scholle, Dorothee Bardiot, Arnaud Marchand, Patrick Chaltin, Lawrence M Blatt, Leonid Beigelman, Julian A Symons, Pierre Raboisson, Zachary A Gurard-Levin, Koen Vandyck, Jerome Deval

Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry

使用自组装单层解吸电离质谱法评估 SARS-CoV-2 3C 类蛋白酶抑制剂

Zachary A Gurard-Levin, Cheng Liu, Andreas Jekle, Ruchika Jaisinghani, Suping Ren, Koen Vandyck, Dirk Jochmans, Pieter Leyssen, Johan Neyts, Lawrence M Blatt, Leonid Beigelman, Julian A Symons, Pierre Raboisson, Michael D Scholle, Jerome Deval

Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)

甲状腺激素受体β激动剂对基因转录的调控在治疗非酒精性脂肪性肝炎(NASH)的临床开发中

Xuan G Luong, Sarah K Stevens, Andreas Jekle, Tse-I Lin, Kusum Gupta, Dinah Misner, Sushmita Chanda, Sucheta Mukherjee, Caroline Williams, Antitsa Stoycheva, Lawrence M Blatt, Leonid N Beigelman, Julian A Symons, Pierre Raboisson, David McGowan, Koen Vandyck, Jerome Deval

Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle

新型强效衣壳组装调节剂可调节乙肝病毒生命周期的多个步骤

Thomas Lahlali, Jan Martin Berke, Karen Vergauwen, Adrien Foca, Koen Vandyck, Frederik Pauwels, Fabien Zoulim, David Durantel